May 11, 2026

Biogen Inc. (BIIB) Stock Analysis: Potential 12% Upside Amid Strong Buy Ratings

Biogen Inc. (NASDAQ: BIIB), a leading player in the healthcare sector, has consistently been in the spotlight for its innovative contributions to the field of biotechnology. With a market capitalization..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth With a 52.60% Revenue Surge

Oscar Health, Inc. (NYSE: OSCR), a key player in the healthcare technology sector, is making waves with its impressive revenue growth of 52.60%. This New York-based company, originally incorporated as..

Insmed Incorporated (INSM) Stock Analysis: Exploring a 102% Potential Upside Amid Robust Revenue Growth

Investors with a keen eye on the biotechnology sector might find Insmed Incorporated (NASDAQ: INSM) an intriguing prospect, especially given its substantial potential upside of 102.12% based on the average..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Powerhouse with Growth Potential and Strategic Vision

Investors eyeing the biotechnology sector should take a closer look at Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a Dublin-based company making significant strides in the healthcare industry. With a market capitalization..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Is a 20.50% Potential Upside Worth the Investment?

Inspire Medical Systems, Inc. (INSP), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its innovative solutions for obstructive sleep apnea (OSA). Despite..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech with 35.91% Potential Upside and Groundbreaking Innovations

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is making waves with its focus on developing groundbreaking muscle activators and inhibitors. Based in South San Francisco, California,..

Labcorp Holdings Inc. (LH) Stock Analysis: A 22% Potential Upside with Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a major player in the healthcare sector, specifically within diagnostics and research, presents an intriguing investment opportunity for those eyeing the medical diagnostics landscape. As..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 42% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector, specifically within the medical care facilities industry, as a robust player offering comprehensive home and alternate site infusion..

Masimo Corporation (MASI) Stock Analysis: Navigating the Healthcare Sector with Steady Growth and Innovation

Masimo Corporation (MASI), a prominent player in the healthcare sector, is carving out a significant niche in the medical devices industry. With a market capitalization of $9.34 billion, Masimo is..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring the 91% Potential Upside in RNA Therapeutics

Atrium Therapeutics, Inc. (NASDAQ: RNA) presents a compelling investment opportunity for those willing to navigate the inherently volatile landscape of biotechnology. With a market capitalization of $202.78 million, this San..

Charles River Laboratories (CRL) Stock Analysis: Harnessing a 17.67% Potential Upside in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With its broad range of services aimed at drug..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling a 73.9% Potential Upside with a Revolutionary Medical Device

Investors seeking growth opportunities in the healthcare sector may want to closely examine TransMedics Group, Inc. (NASDAQ: TMDX). As a pioneering force in medical technology, TransMedics is at the forefront..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a 22.93% Potential Upside

Baxter International Inc. (NYSE: BAX), a seasoned player in the healthcare sector, has long been a trusted provider of medical instruments and supplies. Headquartered in Deerfield, Illinois, the company operates..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 52% Potential Upside in a Booming Biotech Market

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a beacon of innovation in the biotechnology sector, with a market capitalization of $39.39 billion. Headquartered in Cambridge, Massachusetts, Alnylam is a trailblazer..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 27.85% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) stands as a beacon of innovation in the biotechnology industry, specifically targeting RAS-addicted cancers with its precision oncology therapies. With a market capitalization of $30.15..

Repligen Corporation (RGEN): Investor Outlook Reveals 45.62% Potential Upside in Bioprocessing Innovator

Repligen Corporation (NASDAQ: RGEN) stands as a formidable player in the healthcare sector, specifically within the realm of medical instruments and supplies. With a market capitalization of $6.96 billion, this..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 7.81% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may want to turn their attention to Integer Holdings Corporation (NYSE: ITGR), a key player in the medical devices industry. With a current..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a Potential 11.49% Upside

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent player in the global healthcare sector, specializing in medical instruments and supplies with a particular focus on eye health. Headquartered..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a 22.72% Potential Upside in the Diagnostics & Research Sector

Mettler-Toledo International, Inc. (NYSE: MTD), a key player in the Diagnostics & Research industry, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. With a robust market..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 19.67% Potential Upside in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a key player in the healthcare sector specializing in medical devices, presents a promising opportunity for investors with a potential upside of 19.67%. As..

Search

Funds

May 11, 2026

Search

Funds

May 11, 2026

FTSE 100

Funds